NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-70622 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Next Generation Sequencing (NGS) Services Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET
7.1 GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 BGI
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Illumina, Inc.
16.3 Perkinelmer, Inc.
16.4 Eurofins Scientific SE
16.5 Gatc Biotech AG
16.6 Macrogen, Inc.
16.7 Qiagen N.V.
16.8 Genotypic Technology Pvt. Ltd.
16.9 Genewiz, Inc.
16.10 DNA Link, Inc.
16.11 Takara Bio Inc. (Part of Takara Holding Company Inc.)
16.12 Novogene Corporation
16.13 Personalis, Inc.
16.14 LGC Limited (A Part of KKR & Co. L.P.)
16.15 Wuxi Apptec
16.16 Scigenom Labs Pvt. Ltd
16.17 Theragen Etex Co., Ltd.
16.18 Oxford Gene Technology
16.19 Sysmex Corporation
16.20 Genomics Biosci & Tech. Co., Ltd.
16.21 Zymo Research Corp
16.22 Source Bioscience
16.23 Integragen Sa
16.24 Centogene AG
16.25 Otogenetics Corporation
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeTargeted Sequencing/Gene Panels
RNA-Seq
De Novo Sequencing
Exome Sequencing
CHiP-Seq
Whole-genome Sequencing
Methyl-Seq
Other Services
By Technology
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Nanopore Sequencing
True Single Molecule Sequencing (tSMS)
By Application
Diagnostics
  o Oncology
  o Reproductive Health
  o Infectious Diseases
  o Rare Genetic Disorders
  o Others
Drug Discovery
Biomarker Discovery
Microbial Genetics, Agriculture, and Animal Research
Other Applications (Marine Research, Research in Biofuels, Forensic Medicine, Food Safety, and Phylogeographic & Phylogenetic Studies)
By End User
Academic & Government Institutes and Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users (NPOs, Agrigenomics Organizations, and Consumer Genomic Companies)
Companies
BGI
Illumina, Inc.
Perkinelmer, Inc.
Eurofins Scientific SE
Gatc Biotech AG
Macrogen, Inc.
Qiagen N.V.
Genotypic Technology Pvt. Ltd.
Genewiz, Inc.
DNA Link, Inc.
Takara Bio Inc. (Part of Takara Holding Company Inc.)
Novogene Corporation
Personalis, Inc.
LGC Limited (A Part of KKR & Co. L.P.)
Wuxi Apptec
Scigenom Labs Pvt. Ltd
Theragen Etex Co., Ltd.
Oxford Gene Technology
Sysmex Corporation
Genomics Biosci & Tech. Co., Ltd.
Zymo Research Corp
Source Bioscience
Integragen Sa
Centogene AG
Otogenetics Corporation
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.